Altimmune to Participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day to Discuss ADA Takeaways
Altimmune, a clinical-stage biopharmaceutical company listed on Nasdaq under the symbol ALT, will participate in the Piper Sandler 2nd Annual Virtual Obesity Investor Day on June 26, 2024. Company leaders, including CEO Vipin Garg, Ph.D., and Chief Scientific Officer Scott Roberts, Ph.D., will discuss insights from the American Diabetes Association's Scientific Sessions during a fireside chat at 9:30 a.m. EDT. The session will be webcast and accessible via the Events section of the Altimmune website.
- None.
- None.
GAITHERSBURG, Md., June 20, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate in a fireside chat at the Piper Sandler 2nd Annual Virtual Obesity Investor Day, being held on June 26, 2024, to discuss key takeaways from the American Diabetes Association’s (ADA) Scientific Sessions. Details on the fireside chat are as follows:
Title: | Piper Sandler Virtual Obesity Investor Day |
Presenters: | Vipin Garg, Ph.D., Chief Executive Officer Scott Roberts, Ph.D., Chief Scientific Officer |
Date/Time: | Wednesday, June 26, 2024 at 9:30 a.m. EDT |
The session will be webcast and can be accessed by visiting the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.
Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter
Company Contact:
Richard Eisenstadt
Chief Financial Officer
Phone: 240-654-1450
ir@altimmune.com
Investor Contacts:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com
Julia Weilman
Burns McClellan
Phone: 646-732-4443
jweilman@burnsmc.com
Media Contact:
Danielle Cantey
Inizio Evoke Comms
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com
![](https://ml.globenewswire.com/media/Yjg4N2NjMmQtNDc1NC00OTcwLWFkYTAtNzYzNzc1ZGY2YjBlLTEwMjIyNDk=/tiny/Altimmune-Inc.png)
FAQ
What event will Altimmune participate in on June 26, 2024?
Who are the presenters from Altimmune at the Piper Sandler Virtual Obesity Investor Day?
What will Altimmune discuss at the Piper Sandler Virtual Obesity Investor Day?
How can I watch Altimmune's session at the Piper Sandler Virtual Obesity Investor Day?